• Search
  • Helpdesk
  • Sales contact

eCOA in ophthalmology

Last updated: June 24, 2024

There is an extended use of Patient Reported Outcome (PRO) measures in clinical trials used to assess health-related quality of life, symptoms, or perception of health status by the patients participating in clinical research. These measures are increasingly being collected via electronic devices and are, as such, referred to as ePROs.

In ophthalmology trials, the types of ePRO used can be general (SF-36, EQ-5D), vision specific (VFQ-25) or condition specific (glaucoma utility index, Retinopathy Treatment Satisfaction Questionnaire). A very wide range of validated questionnaires are available for use in research and selecting the right ePRO in an ophthalmology study is paramount to the success of a clinical trial.


Discover the five keys for successful ePRO selection in your ophthalmology clinical trial:

Follow us on LinkedIn to stay up-to-date on our latest videos:

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

CTAD Clinical Trial on Alzheimer’s Disesases

16-19 NOV 2026 • Boston, MA, USA
  Meet our colleague Anna Dudalyan at CTAD. Schedule a meeting

8th Early-Phase Clinical Trials in Oncology Meeting

26 NOV 2026 • Paris, France
   Meet our Chief Medical Director Estelle Haenel at the 8th Early-Phase Clinical Trials in Oncology Meeting (8e Rencontres Phases...

OCT West Coast 2027

FEB 11-12 2027 • Burlingame, CA, USA
Meet our colleague Jim Tolley at the Outsourcing in Clinical Trials West Coast 2027 - Arena International Schedule a meeting

SCOPE 2027

MAR 1-4 2027 • Orlando, FL, USA
Meet our team Chris Barden, Chris Kemper and Jim Tolley at Booth #1025 at SCOPE Summit 2027 | March 1-4, 2027...

ACDM 2027

MAR 14-16 2026 • Oslo, Norway
Meet our team Chris Barden and Andrea Murison at Booth #9 at ACDM27 14-16 March 2027 Schedule a meeting